April 11, 2017 / 9:41 PM / in 2 years

Akorn hit with $20.5 million verdict over failure to warn

Generic drugmaker Akorn Inc must pay $20.5 million in a lawsuit by a Georgia teacher who accused the company of failing to warn that one of its products would react adversely with another medication she was already taking, a state court jury has ruled.

The verdict, delivered last week by a jury in Warner Robins, Georgia, was announced on Monday by lawyers for Ann Pope, who was administered an Akorn medication called methylene blue when she underwent surgery in 2013.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2o20XYv

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below